191 – 200 of 315
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2009
-
Mark
Treatment of invasive streptococcal infection with a peptide derived from human high molecular weight kininogen.
(
- Contribution to journal › Article
-
Mark
Pseudomonas aeruginosa CRASP-2 is a novel multifunctional surface protein that binds Factor H, Factor H related protein 1 and plasminogen
2009) 12th European Meeting on Complement in Human Disease In Molecular Immunology 46(14). p.2835-2835(
- Contribution to journal › Published meeting abstract
-
Mark
Protein C inhibitor--a novel antimicrobial agent.
(
- Contribution to journal › Article
-
Mark
SpeB of Streptococcus pyogenes differentially modulates antibacterial and receptor activating properties of human chemokines.
(
- Contribution to journal › Article
-
Mark
The effects of hyperglycaemia on thrombin-activatable fibrinolysis inhibitor
(
- Contribution to journal › Article
-
Mark
SufA of the opportunistic pathogen Finegoldia magna modulates actions of the antibacterial chemokine MIG/CXCL9, promoting bacterial survival during epithelial inflammation.
(
- Contribution to journal › Article
-
Mark
Short leucine-rich glycoproteins of the extracellular matrix display diverse patterns of complement interaction and activation.
(
- Contribution to journal › Article
-
Mark
Biofilm formation by Propionibacterium acnes is a characteristic of invasive isolates.
(
- Contribution to journal › Article
-
Mark
Suppression of sulfonylurea- and glucose-induced insulin secretion in vitro and in vivo in mice lacking the chloride transport protein ClC-3.
(
- Contribution to journal › Article
-
Mark
Tryptophan end-tagging of antimicrobial peptides for increased potency against Pseudomonas aeruginosa.
(
- Contribution to journal › Article